BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6349787)

  • 1. Clinical, pathologic and immunologic features of patients with non-Hodgkin's lymphoma in a leukemic phase. A retrospective analysis of 34 patients.
    Fram RJ; Skarin AT; Rosenthal DS; Pinkus G; Nadler LM
    Cancer; 1983 Oct; 52(7):1220-8. PubMed ID: 6349787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, hematologic, and pathologic features of leukemic T-cell lymphoma.
    Kinoshita K; Kamihira S; Ikeda S; Yamada Y; Muta T; Kitamura T; Ichimaru M; Matsuo T
    Cancer; 1982 Oct; 50(8):1554-62. PubMed ID: 6981451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations.
    Come SE; Jaffe ES; Andersen JC; Mann RB; Johnson BL; DeVita VT; Young RC
    Am J Med; 1980 Nov; 69(5):667-74. PubMed ID: 7001897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphosarcoma cell leukemia and other non-Hodgkin's lymphomas in leukemic phase.
    Mintzer DM; Hauptman SP
    Am J Med; 1983 Jul; 75(1):110-20. PubMed ID: 6344632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the central nervous system in non-Hodgkin's lymphoma.
    Law IP; Dick FR; Blom J; Bergevin PR
    Cancer; 1975 Jul; 36(1):225-31. PubMed ID: 1106832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
    Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of childhood non-Hodgkin's lymphoma.
    Murphy SB; Frizzera G; Evans AE
    Cancer; 1975 Dec; 36(6):2121-31. PubMed ID: 1081906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin's lymphoma.
    Garrett JV; Scarffe JH; Newton RK
    Br J Haematol; 1979 May; 42(1):41-50. PubMed ID: 380628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte markers in non-Hodgkin's lymphomas.
    Payne SV; Smith JL; Jones DB; Wright DH
    Br J Cancer; 1977 Jul; 36(1):57-64. PubMed ID: 329850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell lymphoma-leukemia. Pathologic observations in three cases.
    Whitcomb CC; Olivella JE; Byrne GE
    Cancer; 1983 Oct; 52(7):1202-9. PubMed ID: 6603898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases.
    Weisenburger DD; Nathwani BN; Diamond LW; Winberg CD; Rappaport H
    Cancer; 1981 Sep; 48(6):1415-25. PubMed ID: 6895048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
    Kim H; Nathwani BN; Rappaport H
    Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance.
    Morra E; Lazzarino M; Orlandi E; Pagnucco G; Brusamolino E; Castello A; Inverardi D; Bernasconi C
    Haematologica; 1984; 69(1):15-29. PubMed ID: 6428991
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.
    Said JW; Hargreaves HK; Pinkus GS
    Cancer; 1979 Aug; 44(2):504-28. PubMed ID: 383256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.